Back to Journals » Therapeutics and Clinical Risk Management » Volume 17

Reexamining Ophthalmic Drugs, Safety and Tolerability in Phase 1 Clinical Trials

Total article views   HTML views PDF downloads Totals
4,831 Dovepress* 4,270+ 121 4,391
PubMed Central* 561 159 720
Totals 4,831 280 5,111
*Since 21 October 2021

View citations on PubMed Central and Google Scholar